Source:http://linkedlifedata.com/resource/pubmed/id/17077326
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2007-2-21
|
pubmed:abstractText |
With the use of microarray gene-expression profiling, we analyzed a homogeneous series of 32 patients with systemic anaplastic large-cell lymphoma (ALCL) and 5 ALCL cell lines. Unsupervised analysis classified ALCL in 2 clusters, corresponding essentially to morphologic subgroups (ie, common type vs small cell and "mixed" variants) and clinical variables. Patients with a morphologic variant of ALCL had advanced-stage disease. This group included a significant number of patients who experienced early relapse. Supervised analysis showed that ALK+ALCL and ALK- ALCL have different gene-expression profiles, further confirming that they are different entities. Among the most significantly differentially expressed genes between ALK+ and ALK- samples, we found BCL6, PTPN12, CEBPB, and SERPINA1 genes to be overexpressed in ALK+ ALCL. This result was confirmed at the protein level for BCL-6, C/EBPbeta and serpinA1 through tissue microarrays. The molecular signature of ALK- ALCL included overexpression of CCR7, CNTFR, IL22, and IL21 genes but did not provide any obvious clues to the molecular mechanism underlying this tumor subtype. Once confirmed on a larger number of patients, the results of the present study could be used for clinical and therapeutic management of patients at the time of diagnosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/anaplastic lymphoma kinase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0006-4971
|
pubmed:author |
pubmed-author:BrugièresLaurenceL,
pubmed-author:DelsolGeorgesG,
pubmed-author:DuplantierMarie-MichèleMM,
pubmed-author:EspinosEstelleE,
pubmed-author:GaulardPhilippeP,
pubmed-author:GiuriatoSylvieS,
pubmed-author:LamantLaurenceL,
pubmed-author:RickmanDavid SDS,
pubmed-author:SabourdyFrédériqueF,
pubmed-author:de ReynièsAurélienA
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
109
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2156-64
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17077326-Cell Line, Tumor,
pubmed-meshheading:17077326-Cell Shape,
pubmed-meshheading:17077326-Gene Expression Profiling,
pubmed-meshheading:17077326-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:17077326-Humans,
pubmed-meshheading:17077326-Immunohistochemistry,
pubmed-meshheading:17077326-Lymphoma, Large-Cell, Anaplastic,
pubmed-meshheading:17077326-Protein-Tyrosine Kinases,
pubmed-meshheading:17077326-RNA, Messenger,
pubmed-meshheading:17077326-Receptor Protein-Tyrosine Kinases,
pubmed-meshheading:17077326-Tissue Array Analysis
|
pubmed:year |
2007
|
pubmed:articleTitle |
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes.
|
pubmed:affiliation |
Institut National de la Santé et de la Recherche Médicale (INSERM) U563 Centre de physiopathologie Toulouse Purpan, Toulouse, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|